Table 1. Bacterial strains and phage used in this study.
Strain/phage | Description or relevant genotype | Reference |
Bacterial strains | ||
UTI89 | K1 Escherichia coli cystitis isolate | [49] |
UTI89 ΔRegion I | Region I (kps) K1 capsule mutant | [28] |
UTI89 ΔRegion II | Region II (neu) K1 capsule synthesis mutant | [28] |
UTI89 Δ kpsM | K1 capsule export mutant | [28] |
DS17 | Escherichia coli K5 pyelonephritis isolate; K5 encapsulated, susceptible to K5 specific phage | [50] |
EV36 | K-12/K1 hybrid produced by conjugation with an Hfr kps + strain; K1 encapsulated, susceptible to K1-specific phage. | [51] |
CFT073 | K2 Escherichia coli urosepsis isolate | [52] |
536 | K15 Escherichia coli urinary tract isolate | [53] |
Phage | ||
T7 phage (T7φ) | Inhibited by K1 capsule | [54] |
K1F phage (K1Fφ) | K1 capsule specific | [55] |
K5 phage (K5φ) | K5 capsule specific | [56] |